Dividend investors often find themselves weighing higher current income against cost, growth potential, and overall returns. Few comparisons illustrate that balance as clearly as KNG versus SCHD. The two funds do not share identical mandates; instead, they offer distinct paths to U.S. equity income. KNG generates elevated distributions by selling options against an equal-weighted basket of dividend aristocrats, while SCHD provides a market-cap-weighted portfolio of quality dividend growers at a much lower fee. Understanding these structural differences matters when constructing an income allocation that aligns with an investor’s views on volatility, upside participation, and ongoing costs. I also checked this using Tickeron’s AI Screener to see how the two line up on key metrics.
KNG follows an equal-weighted index of S&P 500 Dividend Aristocrats—companies that have increased dividends for at least 25 straight years—and adds a partial covered-call strategy. The goal is to turn equity exposure into a higher monthly income stream. The fund holds about 140 securities, with the largest position usually under 2% of assets. Top holdings often include Becton Dickinson, Target, Nordson, Emerson Electric, Fastenal, and Automatic Data Processing.
Sector weights tilt defensive and industrial: consumer staples near 23%, industrials around 20%, financials about 13%, healthcare close to 11%, and materials roughly 10%, with lighter technology and energy exposure. The 0.74% expense ratio reflects the income-focused design, which also tends to produce a lower beta. The built-in tradeoff is clear—the options layer can limit gains during strong market rallies in return for higher distributions.
SCHD tracks the Dow Jones U.S. Dividend 100 Index, selecting companies based on dividend consistency, yield, cash flow, and fundamental quality. The portfolio contains roughly 100 to 104 names, market-cap weighted with caps to control concentration. Leading holdings typically include Texas Instruments, Chevron, ConocoPhillips, Procter & Gamble, Coca-Cola, Amgen, Home Depot, and Merck.
Sector exposure centers on healthcare at about 21%, consumer defensive near 19–20%, energy around 15%, and technology 13–16%, with financials, industrials, and communication services rounding out the allocation. Its 0.06% expense ratio ranks among the lowest in the category. With substantial assets and high trading volume, SCHD offers tight spreads and solid liquidity, along with a lower beta and a track record since 2011. From what I see, the ultra-low fee helps preserve more of the income over time.
Both funds sit within the broader U.S. dividend and quality-value space, influenced by interest-rate expectations, sector rotation, and demand for defensive cash flow. Rising rate expectations can pressure high-yield and bond-like equity strategies, while a preference for stability often favors dividend payers and staples-heavy portfolios. KNG’s staples and industrials tilt makes it responsive to pricing power and manufacturing trends, whereas SCHD’s energy and healthcare weights link it to commodity moves, pharma results, and policy shifts in those areas. Macro and regulatory factors can influence relative performance, though both remain tied to broader equity market risk.
Recent market action has highlighted the cost and structure differences. SCHD has generally kept stronger total-return flexibility during equity advances, helped by energy and healthcare leadership plus the minimal fee that retains more income. Its lower volatility and dividend-growth focus support steadier positioning across cycles. KNG, in contrast, has produced a notably higher distribution yield, often in the mid-to-high single digits thanks to options income, but its equal-weighted staples and industrials focus and higher 0.74% cost have weighed on total returns during risk-on moves. In broad terms, SCHD delivers better upside capture and cost efficiency, while KNG emphasizes current income at the expense of capital appreciation and fee efficiency. I’m watching this closely as the cost differential compounds.
Weighing structural cost, diversification, liquidity, and total-return flexibility, the analysis favors SCHD. Its 0.06% expense ratio is more than twelve times lower than KNG’s 0.74% fee—a lasting edge that compounds over long periods. SCHD’s quality-screened, market-cap-weighted portfolio with single-stock caps provides broader sector balance and full equity upside, while strong liquidity aids efficient trading. KNG’s higher yield remains a valid point for income-focused investors, but the options overlay and equal-weighted defensive tilt tend to limit total returns and add structural costs. On a risk-adjusted basis, SCHD offers the more resilient and cost-effective profile for most long-term investors.
When comparing income ETFs like these, I often rely on Tickeron’s AI Screener to quickly filter and evaluate positioning across technical patterns, fundamentals, and performance metrics. It surfaces relevant data efficiently and supports more informed decisions without manual effort. Explore the AI Screener to run your own side-by-side analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for SCHD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
SCHD moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHD advanced for three days, in 265 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Aroon Indicator entered an Uptrend today. In 282 of 364 cases where SCHD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.
The 10-day RSI Indicator for SCHD moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In 34 of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at 79%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SCHD as a result. In 62 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for SCHD turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 36 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
SCHD broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows